bioRxivCancer BiologyPreprint
Calorie Restriction Outperforms Bariatric Surgery in a Murine Model of Obesity and Triple-Negative Breast Cancer
M. F. Coleman, K. K. Camp, T. L. McFarlane, S. S. Doerstling, S. A. Khatib, E. T. Rezeli, A. G. Lewis, A. J. Pfeil, L. A. Smith, F. Fouladi, W. Gong, E. M. Glenny, J. S. Parker, G. L. Milne, I. M. Carroll, A. A. Fodor, R. Seeley, S. D. Hursting
Abstract
Obesity promotes triple-negative breast cancer (TNBC), and effective interventions are urgently needed to break the obesity-TNBC link. Epidemiologic studies indicate that bariatric surgery reduces TNBC risk, while evidence is limited or conflicted for weight loss via low-fat diet (LFD) or calorie restriction (CR). Using a murine model of obesity- driven TNBC, we compared the antitumor effects of vertical sleeve gastrectomy (VSG) with LFD, chronic CR, and intermittent CR. Each intervention generated weight and fat loss and suppressed tumor growth relative to obese mice (greatest suppression with CR). VSG and CR regimens exerted both similar and unique effects, as assessed using multi-omic approaches, in reversing obesity-associated transcriptional, epigenetic, secretome, and microbiota changes and restoring antitumor immunity. Thus, in a murine model of TNBC, bariatric surgery and CR each reverse obesity-driven tumor growth via shared and distinct antitumor mechanisms, and CR is superior to VSG in reversing obesitys procancer effects.
- organism: mouse
- assay: bulk RNA-seq
- assay: metagenomics
- assay: proteomics
- assay: DNA methylation
- research focus: cancer & tumor microenvironment
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Response to immune checkpoint blockade improved in pre-clinical model of breast cancer after bariatric surgery
L. M. Sipe, M. Chaib, … L. Makowski·bioRxiv·Mar 30, 2022
- Preventing ovariectomy-induced weight gain decreases tumor burden in rodent models of obesity and postmenopausal breast cancer.
E. A. Wellberg, K. A. Corleto, … E. D. Giles·bioRxiv·Oct 18, 2021
- Obesity Impairs the Antitumor Activity of CAR-T Cells in Triple-Negative Breast Cancer
Hannah M. Malian, Caroline Marnata, … Michael F. Coleman·npj Breast CancerPeer-reviewed·Sep 29, 2026
- Trem2 deficiency attenuates breast cancer tumor growth in lean, but not obese or weight loss, mice and is associated with alterations of clonal T cell populations
Elysa W. Pierro, Matthew A. Cottam, … Alyssa H. Hasty·Cancer ResearchPeer-reviewed·Jan 22, 2025
- Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer
Z. Zhao, J. Wang, … V. L. Bae-Jump·bioRxiv·Feb 2, 2024
- Tirzepatide restricts obesity-related tumor growth by reversing metabolic dysregulation and rescuing CD8+ T cell function
E. M. Glenny, M. F. Coleman, … S. D. Hursting·bioRxiv·Jan 20, 2024